Where's the HIV Glossary?

The HIV Glossary formerly hosted on our site has been removed.

 

If you think you may have been infected with HIV/AIDS, please find a place to get a free, confidential HIV test.

 


HIV counselor in front of magnet board

HIV Info

Of the more than one million people estimated to be living with HIV in the United States, one in eight don't know they're infected. The best way to fight HIV is to know your status.


If you think you may have been exposed to HIV, we encourage you to get a confidential HIV test in your region.

Have questions about HIV/AIDS? We have answers to Frequently Asked Questions.

Want to learn more about PrEP? PrEP is a method of HIV prevention that people who are HIV-negative may be able to use. It involves taking a daily medication, and other thing like regular HIV testing, to prevent HIV transmission. Learn more about PrEP.

HIV stands for Human Immunodeficiency Virus. This is a virus that attacks the immune system and can cause AIDS (Acquired Immune Deficiency Syndrome).  

Over time, and without treatment, HIV gradually weakens the body's immune system leaving it vulnerable to many infections and cancers that do not normally develop.

AIDS is the late stage of an HIV infection. An AIDS diagnosis indicates HIV has weakened the body's immune system. A person living with AIDS is at risk of suffering from life-threatening infections or cancers.

Learn more about acquiring HIV, testing for HIV, and HIV treatment options.

 

Switch on your HIV Smarts with BETA

The Bulletin of Experimental Treatments for AIDS is your bright and brainy source on new developments in HIV prevention, evolving approaches to HIV treatment, and strategies for living well with the virus.

Latest BETA News

Two new HIV drugs, Doravirine and Bictegravir, suppress viral loads in studies and proceed to Phase 3 testing

Two new HIV drugs, Doravirine and Bictegravir, suppress viral loads in studies and proceed to Phase 3 testing

A pair of new drugs—Merck’s doravirine and Gilead Sciences’ bictegravir—showed potent activity against HIV in clinical trials, researchers reported at the Conference on Retroviruses and Opportunistic Infections (CROI) last week … Read More

“I’ve heard of hairy palms, but a hairy tongue?!” HIV & oral health concerns

“I’ve heard of hairy palms, but a hairy tongue?!” HIV & oral health concerns

Twice a month, the San Francisco AIDS Foundation program Positive Force hosts free The Dr. Is In events for our HIV-positive community. Dr. Neal Sheran, the Special Populations Clinical Chief … Read More

Simpler HIV treatment, with only 2 drugs, keeps viral loads suppressed

Simpler HIV treatment, with only 2 drugs, keeps viral loads suppressed

Antiretroviral therapy (ART) using just two approved drugs—dolutegravir and rilpivirine —kept HIV suppressed for a year in people with undetectable viral load who switched from a three- or four-drug combo, … Read More

Research will see if antibodies can more selectively target & kill HIV-infected cells

Research will see if antibodies can more selectively target & kill HIV-infected cells

Early in January, Gilead Sciences announced an astounding $22 million HIV cure grants program benefitting 12 research teams around the world. The projects supported range in scope from basic science … Read More

Research shows 47% reduction in STIs among gay men who took doxycycline after sex

Research shows 47% reduction in STIs among gay men who took doxycycline after sex

BETA is reporting from the 2017 Conference on Retroviruses and Opportunistic Infections (CROI) this week in Seattle—bringing you the latest news, updates, and research on HIV treatment and prevention. The … Read More

Are painkillers the new “gateway” drug? New research says yes…

Are painkillers the new “gateway” drug? New research says yes…

BETA is reporting from the 2017 Conference on Retroviruses and Opportunistic Infections (CROI) this week in Seattle—bringing you the latest news, updates, and research on HIV treatment and prevention. About … Read More

One-stop sexual health: PrEP services at your local pharmacy

One-stop sexual health: PrEP services at your local pharmacy

BETA is reporting from the 2017 Conference on Retroviruses and Opportunistic Infections (CROI) this week in Seattle—bringing you the latest news, updates, and research on HIV treatment and prevention. Over … Read More

See more articles on the BETA Blog...